Skip to main content

Advertisement

Log in

Comparative Study of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP) in Management of Oral Submucous Fibrosis (OSMF)

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

This study aimed to compare the results of injection triamcinolone and hyaluronidase combination with injection Platelet Rich Plasma (PRP) in management of Oral Submucous Fibrosis (OSMF). Present study was carried out in randomly divided two groups of 30 patients each of OSMF who all are presented with chief complain of reduced mouth opening. Group A patients were given 1 ml of injection triamcinolone and hyaluronidase combination. Group B patients received 1 ml of injection Platelet Rich Plasma. Both injections were given intralesionally once a week for 6 weeks. Results of ANOVA shows significant better results in improving mouth opening in group B patients receiving injection Platelet Rich Plasma as a treatment. In Group A, patients shows improvement in Maximum interincisal distance (MIID) of mean 6.51 ± 1.02 mm as compared to the patients in group B shows improvement in MIID of mean 9.53 ± 1.06 mm (p value < 0.05). Treatment of OSMF with injection Platelet Rich Plasma is a novel method and found to be more efficient than treatment with injection triamcinolone and hyaluronidase combination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Babu S, Bhat RV, Kumar PU (1996) A comparative clinicopathological study of oral submucous fibrosis in habitual chewers of pan masala and betel quid. Clin Toxicol 34:317–322

    CAS  Google Scholar 

  2. More CB, Rao NR (2019) Proposed clinical definition for oral submucous fibrosis. J Oral Biol Craniofac Res 9:311–314

    PubMed  PubMed Central  Google Scholar 

  3. Hughes MW, Chuong CM (2003) A mouthful of epithelial-mesenchymal interactions. J Invest Dermatol 121:7–8

    Google Scholar 

  4. Gupta SC, Singh M, Khanna S, Jain S (2004) Oral submucous fibrosis with its possible effect on eustachian tube functions: a tympanometric study. Ind J Otolaryngol Head Neck Surg 56:183–185

    CAS  Google Scholar 

  5. Rajalalitha P, Vali S (2005) Molecular pathogenesis of oral submucous fibrosis-a collagen metabolic disorder. J Oral Pathol Med 34:321–328

    CAS  PubMed  Google Scholar 

  6. Choudhari SS, Kulkarni DG, Patankar S, Kheur SM, Sarode SC, Sarode GS, Patil S (2018) Angiogenesis and fibrogenesis in oral submucous fibrosis: a viewpoint. J Contemp Dent Pract 19(2):242–245

    PubMed  Google Scholar 

  7. Khan S, Chatra L, Prashanth SK, Veena KM, Rao PK (2012) Pathogenesis of oral submucous fibrosis. J Cancer Res Ther 8:199–203

    PubMed  Google Scholar 

  8. Lord GA, Lim CK, Warnakulasuriya S, Peters TJ (2002) Chemical and analytical aspects of areca nut. Addict Biol 7:99–102

    CAS  PubMed  Google Scholar 

  9. Hernandez BY, Zhu X, Goodman MT, Gatewood R, Mendiola P, Quinata K et al (2017) Betel nut chewing, oral premalignant lesions, and the oral microbiome. PLoS ONE 12:e0172196

    PubMed  PubMed Central  Google Scholar 

  10. Mathew P, Austin RD, Varghese SS (2014) Estimation and comparison of copper content in raw areca nuts and commercial areca nut products: Implications in increasing prevalence of oral submucous fibrosis (OSMF). J Clin Diagn Res 8:247–249

    PubMed  PubMed Central  Google Scholar 

  11. Chiu CJ, Chang ML, Chiang CP, Hahn LJ, Hsieh LL, Chen CJ (2002) Interaction of collagen-related genes and susceptibility to betel quidinduced oral submucous fibrosis. Cancer Epidemiol Biomarkers Prev 11:646–653

    CAS  PubMed  Google Scholar 

  12. More C, Shah P, Rao N, Pawar R (2015) Oral submucous fibrosis: an overview with evidence-based management. Int J Oral Health Sci Adv 3:40–49

    Google Scholar 

  13. Ha VK, Kandula S, NingappaChinnannavar S, Rout P, Mishra S, Bajoria AA (2019) Oral submucous fibrosis: correlation of clinical grading to various habit factors. J Int Soc Prevent Communit Dent 9:363–371

    Google Scholar 

  14. Das M, Manjunath C, Srivastava A, Malavika J, Ameena MV (2017) Epidemiology of oral submucous fibrosis: a review. Int J Oral Health Med Res 3:126–129

    Google Scholar 

  15. Eipe N (2005) The chewing of betel quid and oral submucous fibrosis and anesthesia. Anesth Analg 100:1210–1213

    PubMed  Google Scholar 

  16. Paymaster JC (1956) Cancer of the buccal mucosa; a clinical study of 650 cases in Indian patients. Cancer 9(3):431–435

    CAS  PubMed  Google Scholar 

  17. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM (2007) Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 36(1):25–29

    PubMed  Google Scholar 

  18. Arakeri G, Patil SG, Aljabab AS, Lin KC, Merkx MA, Gao S et al (2017) Oral submucous fibrosis: an update on pathophysiology of malignant transformation. J Oral Pathol Med 46(6):413–417

    PubMed  Google Scholar 

  19. Gupta S, Jawanda MK (2021) Oral submucous fibrosis: An overview of a challenging entity. Ind J Dermatol Venereol Leprol 87:768–777

    Google Scholar 

  20. Rao NR, Villa A, More CB, Jayasinghe RD, Kerr AS, Johnson NW (2020) Oral submucous fibrosis: a contemporary narrative review with a proposed interprofessional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg 49:1–10

    Google Scholar 

  21. More C, Peter R, Nishma G, Chen Y, Rao N (2018) Association of Candida species with oral submucous fibrosis and oral leukoplakia: A case control study. Ann Clin Lab Res 06:248

    Google Scholar 

  22. Gondivkar SM, Gadbail AR, Sarode SC, Gondivkar RS, Patil S, Gaikwad RN, Yuwanati M (2020) Clinical efficacy of mouth exercising devices in oral submucous fibrosis: a systematic review. J Oral Biol Craniofac Res 10:315–320

    PubMed  PubMed Central  Google Scholar 

  23. Mahajan AD, Tatu RJ, Shenoy NA, Sharma VS (2010) Surgical management of oral submucous fibrosis in an edentulous patient: a procedural challenge. Natl J Maxillofac Surg 1(2):161–163. https://doi.org/10.4103/0975-5950.79221. (PMID:22442590;PMCID:PMC3304202)

    Article  PubMed  PubMed Central  Google Scholar 

  24. Gupta M, Pachauri A, Singh SK, Ahuja R, Singh P, Mishra SSS (2014) Recent advancements in oral submucous fibrosis management: an overview. Bangladesh J Dent Res Educ 4(2):88–90

    Google Scholar 

  25. Kumar K, Saraswathi TR, Ranganathan K (2007) Oral submucous fibrosis: a clinico-histopathologic study in Chennai. Ind J Dent Res 18:90–95

    Google Scholar 

  26. Laxmipathi G (1980) Hyalase in submucous fibrosis in oral cavity. Jaipur, India, In: 32nd annual conference of the association of otolaryngologists of India

  27. Amable PR, Carias RB, Teixeira MV et al (2013) Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther 4:67

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Xu J, Gou L, Zhang P, Li H, Qiu S (2020) Platelet-rich plasma and regenerative dentistry. Aust Dent J 65(2):131–142. https://doi.org/10.1111/adj.12754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Everts P, Onishi K, Jayaram P, Lana JF, Mautner K (2020) Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 21(20):7794. https://doi.org/10.3390/ijms21207794

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Rozman P, Bolta Z (2007) Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerol Alp Pannonica Adriat 16:156–165

    CAS  PubMed  Google Scholar 

  31. More CB, Das S, Patel H, Adalja C, Kamatchi V, Venkatesh R (2012) Proposed clinical classification for oral submucous fibrosis. Oral Oncol 48(3):200–202

    PubMed  Google Scholar 

  32. Passi D, Bhanot P, Kacker D, Chahal D, Atri M, Panwar Y (2017) Oral submucous fibrosis: newer proposed classification with critical updates in pathogenesis and management strategies. Natl J Maxillofac Surg 8:89–94

    PubMed  PubMed Central  Google Scholar 

  33. Rajendran R (2004) Familial occurrence of oral submucous fibrosis: Report of eight families from northern Kerala, south India. Ind J Dent Res 15:139–144

    CAS  Google Scholar 

  34. Khan AM, Sheth MS, Purohit RR (2016) Effect of areca nut chewing and maximal mouth opening in school going children in Ahmedabad. Indian J Med Paediatr Oncol 37:239–341

    PubMed  PubMed Central  Google Scholar 

  35. Jain A, Saumya T (2019) Oral submucous fibrosis in paediatric patients: A systematic review and protocol for management. Int J Surg Oncol 2019:3497136

    PubMed  PubMed Central  Google Scholar 

  36. Shreedevi B, Shaila M, Sreejyothi HK, Gururaj MP (2017) Genotoxic effect of local & commercial areca nut & tobacco products—A review. Int J Health Sci Res 7:326–331

    Google Scholar 

  37. Coman DR, Mccutcheon MA, Zeidman I (1947) Failure of hyaluronidase to increase in invasiveness of neoplasms. Cancer Res 7(6):383–385

    CAS  PubMed  Google Scholar 

  38. Laxmipathi G. (1980) Hyalase in Submucous Fibrosis in Oral Cavity. Jaipur, India, In: 32nd annual conference of the association of otolaryngologists of India

  39. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85(6):638–646

    CAS  PubMed  Google Scholar 

  40. Anitua E (2001) The use of Plasma Rich Growth Factors(PRGF) in oral surgery. Pract Proced Aesthet Dent 13:487–493

    CAS  PubMed  Google Scholar 

  41. Marx RE (2001) Platelet rich plasma (PRP): what is PRP and what is not PRP? Implant Dent 10:225–228

    CAS  PubMed  Google Scholar 

  42. Whitman DH, Berry RL, Green DM (1997) Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55:1294–1299

    CAS  PubMed  Google Scholar 

  43. Hydri AS et al (2020) Comparison of triamcinolone versus platelet rich plasma injection for improving trismus in oral submucous fibrosis. J Bahria Univ Med Dental College 10(1):58–62

    Google Scholar 

  44. Manjunath K, Rajaram PC, Saraswathi TR, Sivapathasundharam B, Sabarinath B, Koteeswaran D, Krithika C (2011) Evaluation of oral submucous fibrosis using ultrasonographic technique: a new diagnostic tool. Indian J Dent Res 22:530–536

    CAS  PubMed  Google Scholar 

  45. Ranganathan K, Devi M, Joshua E, Kirankumar K, Saraswathi T (2004) Oral submucous fibrosis: a case-control study in Chennai, South India. J Oral pathol Med: Official Publ Int Assoc Oral Pathol Am Acad Oral Pathol 33:274–277. https://doi.org/10.1111/j.0904-2512.2004.00116.x

    Article  CAS  Google Scholar 

  46. Kakar PK, Puri RK, Venkatachalam VP (1985) Oral submucous fibrosis—treatment with hyalase. J Laryngol Otol 99(1):57–60

    CAS  PubMed  Google Scholar 

  47. James L, Shetty A, Rishi D, Abraham M (2015) Management of oral submucous fibrosis with injection of hyaluronidase and dexamethasone in Grade III Oral Submucous fibrosis: a retrospective study. J Int Oral Health : JIOH 7:82–85

    PubMed  PubMed Central  Google Scholar 

  48. Ahmed N et al (2020) Comparative study between PRP and hyluronidase injection on fibrous site for OSMF. Int J Appl Res 6:256–259

    Google Scholar 

  49. Gopinath D, Hui LM, Veettil SK, Balakrishnan Nair A, Maharajan MK (2022) Comparative efficacy of interventions for the management of oral submucous fibrosis: a systematic review and network meta-analysis. J Pers Med 12(8):1272

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding sources.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepankar Chandrakapure.

Ethics declarations

Conflict of Interest

None declared.

Ethical Approval

The study was approved by the Institutional Ethics Committee.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chandrakapure, D., Sachdeva, K., Agarwal, K. et al. Comparative Study of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP) in Management of Oral Submucous Fibrosis (OSMF). Indian J Otolaryngol Head Neck Surg 75, 3725–3732 (2023). https://doi.org/10.1007/s12070-023-03912-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-023-03912-0

Keywords

Navigation